Barratt Developments welcomes Jasi Halai to its Board as Independent Director

– UK, London –  Barratt Developments PLC (LON: BDEV) today announced the appointment of Jasi Halai to its Board as an Independent Non-Executive Director, effective from 1st January 2023.

“I am delighted to welcome Jasi to the Barratt Board. Jasi will bring a wealth of financial and business skills and experience, which complement those of the other Board members and which will be of great value to the Company over the coming years”, said Board Chairman, John Allan.

Jasi will also join the Audit, Nomination, Remuneration, and Sustainability Committees.

About Jasi Halai

Jasi Halai is COO for 3i and was appointed to the Board of 3i Group plc on 12 May 2022. She is also a member of the 3i Group plc Executive, Investment, Group Risk, and ESG Committees. Jasi is also a non-executive director at Porvair Plc, a position she will relinquish at the end of their FY22 audit process in January 2023. She is a Chartered Management Accountant and holds an MSc in investment management from the CASS Business School.

Jasi joined 3i in 2005 and has held a variety of posts in the business, most recently as Group Financial Controller and Operating Officer. Before joining 3i, she worked for CDC Group (now British International Investment) and at Actis.

Jasi Halai said: “I am delighted to be joining the Barratt Board and to be part of a Company that leads its industry in terms of quality and sustainability while putting its customers at the heart of everything it does. I look forward to working with the Barratt Board and the management team in driving the Group’s strategy forward”.

For more information: https://www.barrattcareers.co.uk/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.